NIPH Stock Overview
Develops, produces, and sells pharmaceutical products in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 2 more risks
My Notes
Capture your thoughts, links and company narrative
EI- Nile Co. for Pharmaceuticals and Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م55.83 |
| 52 Week High | ج.م114.37 |
| 52 Week Low | ج.م44.60 |
| Beta | 0.23 |
| 1 Month Change | 1.10% |
| 3 Month Change | -21.14% |
| 1 Year Change | -32.82% |
| 3 Year Change | 95.35% |
| 5 Year Change | 145.08% |
| Change since IPO | 273.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | -5.1% | -2.7% | -1.5% |
| 1Y | -32.8% | 31.9% | 28.7% |
Return vs Industry: NIPH underperformed the EG Pharmaceuticals industry which returned 27.9% over the past year.
Return vs Market: NIPH underperformed the EG Market which returned 27.5% over the past year.
Price Volatility
| NIPH volatility | |
|---|---|
| NIPH Average Weekly Movement | 20.0% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in EG Market | 8.8% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: NIPH's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: NIPH's weekly volatility has increased from 11% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Eldin Hajjaj | www.nilepharma.com.eg |
EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt. The company offers tablets, capsules, ampoules, powders, gels and creams, syrups, suppositories, lotions, shampoos, ointments, mouthwashes, powder solutions, and nasal and midodrine drops. It also exports its products to the countries in the Middle East.
EI- Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary
| NIPH fundamental statistics | |
|---|---|
| Market cap | ج.م565.28m |
| Earnings (TTM) | ج.م24.65m |
| Revenue (TTM) | ج.م885.62m |
22.9x
P/E Ratio0.6x
P/S RatioIs NIPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIPH income statement (TTM) | |
|---|---|
| Revenue | ج.م885.62m |
| Cost of Revenue | ج.م707.75m |
| Gross Profit | ج.م177.88m |
| Other Expenses | ج.م153.23m |
| Earnings | ج.م24.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.43 |
| Gross Margin | 20.08% |
| Net Profit Margin | 2.78% |
| Debt/Equity Ratio | 110.6% |
How did NIPH perform over the long term?
See historical performance and comparisonDividends
6.6%
Current Dividend Yield152%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:20 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EI- Nile Co. for Pharmaceuticals and Chemical Industries is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|